Wanjia Group Holdings Limited (0401.HK)

0.090 +0.019 (+26.76%) As of 02:00PM HKT. Market open.

Wanjia Group Holdings Limited

Tower 1
Suite 1801, 18th Floor The Gateway, Harbour City 25 Canton Road
Kowloon
Hong Kong
852 2366 3375
https://www.wanjia-gp.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 198

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jia Jun Wang	CEO & Executive Director	1.72M	N/A	1989
Mr. Sze Kin Tam	Company Secretary & Financial Controller	N/A	N/A	1970

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.

Corporate governance

Wanjia Group Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.